ClinicalTrials.Veeva

Menu
P

Pasadena Clinical Trials | Pasadena, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lorundrostat
VRDN-003
ESK-001
SUZ
Sugar
Suzetrigine
Ustekinumab
Deucravacitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 11 total trials

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes (ONWARDS 11)

This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investi...

Enrolling
Diabetes Mellitus, Type 1
Drug: Insulin glargine
Drug: Insulin icodec

This is a clinical trial assessing the efficacy, safety, and tolerability of an investigational drug, VRDN-003, in participants with active Thyroid E...

Active, not recruiting
Thyroid Eye Disease
Drug: VRDN-003
Drug: Placebo

This is a clinical trial assessing the efficacy, safety, and tolerability of an investigational drug, VRDN-003, in participants with chronic Thyroid...

Active, not recruiting
Thyroid Eye Disease
Drug: Placebo
Drug: VRDN-003
Locations recently updated

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine in participants with pain associated with diabetic per...

Enrolling
Diabetic Peripheral Neuropathic Pain
Drug: Placebo (matched to SUZ)
Drug: Suzetrigine

The objective of the ESK-001-018 long term extension is to evaluate the safety and efficacy of ESK-001 over time. The scientific questions it aims to...

Active, not recruiting
Psoriasis
Severe Psoriasis
Drug: Open-Label Envudeucitinib
Drug: Blinded Envudeucitinib
Locations recently updated

A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis

Enrolling
Plaque Psoriasis
Drug: Ustekinumab
Drug: Deucravacitinib

This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypert...

Active, not recruiting
Hypertension
Drug: lorundrostat
Drug: Placebo

The goal of this study is to see if directing insulin to the liver will improve the low blood sugar that sometimes happens when injecting insulin in...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Lispro
Drug: HDV-Lispro

Trial sponsors

A
M
V
Bristol-Myers Squibb (BMS) logo
D
Moderna logo
Novo Nordisk logo
Vertex Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems